Atropine (hydrobromide)
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Atropine (hydrobromide)
Description :
Atropine (Tropine tropate) hydrobromide is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine hydrobromide inhibits ACh-induced relaxations in human pulmonary veins. Atropine hydrobromide can be used for research of anti-myopia and bradycardia[1][2][3][4].CAS Number :
[6415-90-3]Product Name Alternative :
Tropine tropate (hydrobromide) ; DL-Hyoscyamine (hydrobromide)UNSPSC :
12352005Target :
MAChRType :
Reference compoundRelated Pathways :
GPCR/G Protein; Neuronal SignalingApplications :
Neuroscience-NeuromodulationField of Research :
Neurological Disease; Cardiovascular Disease; CancerAssay Protocol :
https://www.medchemexpress.com/atropine-hydrobromide.htmlSolubility :
10 mM in DMSOSmiles :
O=C(O[C@@H]1C[C@@H](N2C)CC[C@@H]2C1)C(CO)C3=CC=CC=C3.BrMolecular Formula :
C17H24BrNO3Molecular Weight :
370.28References & Citations :
[1]McBrien NA, et, al. How does atropine exert its anti-myopia effects? Ophthalmic Physiol Opt. 2013 May;33 (3) :373-8.|[2]Morhardt JE. Heart rates, breathing rates and the effects of atropine and acetylcholine on white-footed mice (Peromyscus sp.) during daily torpor. Comp Biochem Physiol. 1970 Mar 15;33 (2) :441-57.|[3]Carr BJ, et, al. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro. Invest Ophthalmol Vis Sci. 2018 Jun 1;59 (7) :2778-2791.|[4]Walch L, et, al. Evidence for a M (1) muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol. 2000 May;130 (1) :73-8.Shipping Conditions :
Room temperatureScientific Category :
Reference compound1Clinical Information :
LaunchedIsoform :
MAChR4

